Mesenteric Lymphatic Ducts Ligation Decreases the Degree of Gut-Induced Lung Injury in a Portal Vein Occlusion and Reperfusion Canine Model

Journal of Surgical Research

Volumn 154, Issue 1, 2009, Pages 45-50

  Liu, Chang ^a   Wu, Qifei ^a   Li, Quanyuan ^a   Liu, Dong ^a   Su, Haibo ^a   Shen, Naiying ^a   Tai, Minghui ^a   Lv, Yi ^a  

^a First Affiliated Hospital   (China)

Author keywords

canine; cytokines; lymph; mesenteric lymphatic duct; portal vein occlusion

Indexed keywords

CYTOKINE; ENDOTOXIN; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; INTESTINE; INTESTINE INJURY; LIGATION; LUNG; LUNG INJURY; MALE; MESENTERY LYMPH NODE; NONHUMAN; PERMEABILITY; PORTAL VEIN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; REPERFUSION; THORACIC DUCT;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; INTESTINES; LIGATION; LUNG INJURY; LYMPHATIC DISEASES; PORTAL VEIN; REPERFUSION; REPERFUSION INJURY; VASCULAR DISEASES;

EID: 67349096386     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.06.006     Document Type: Article

References (28)

1. Emond J., Wachs M.E., Renz J.F., et al. Total vascular exclusion for major hepatic surgery in patients with abnormal liver parenchyma. Arch Surg 130 (1995) 824
2. Smyrniotis V.E., Kostopanagiotou G.G., Contis J.C., et al. Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: Prospective study. World J Surg 27 (2003) 765
3. Malassagne B., Cherqui D., Alon R., et al. Safety of selective vascular clamping for major hepatectomies. J Am Coll Surg 187 (1998) 482
4. Liu D.L., Jeppsson B., Hakansson C.H., et al. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 131 (1996) 442
5. Nuzzo G., Giuliante F., Gauzolino R., et al. Liver resections for hepatocellular carcinoma in chronic liver disease: Experience in an Italian centre. Eur J Surg Oncol 33 (2007) 1014
6. Man K., Fan S.T., Ng I.O., et al. Tolerance of the liver to intermittent Pringle maneuver in hepatectomy for liver tumors. Arch Surg 134 (1999) 533
7. Mura M., Andrade C.F., Han B., et al. Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock 28 (2007) 227
8. Pierro A., and Eaton S. Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg 13 (2004) 11
9. Tian X.F., Zhang X.S., Li Y.H., et al. Proteasome inhibition attenuates lung injury induced by intestinal ischemia reperfusion in rats. Life Sci 79 (2006) 2069
10. Caty M.G., Guice K.S., Oldham K.T., et al. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia/reperfusion. Ann Surg 212 (1990) 694
11. Perng W.C., Wu C.P., Chu S.J., et al. Effect of hyperbaric oxygen on endotoxin-induced lung injury in rats. Shock 21 (2004) 370
12. Chu S.J., Perng W.C., Hung C.M., et al. Effects of various body temperatures after lipopolysaccharide induced lung injury in rats. Chest 128 (2005) 327
13. Deitch E.A. Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7 (2001) 92
14. Cavriani G., Domingos H.V., Soares A.L., et al. Lymphatic system as a path underlying the spread of lung and gut injury after intestinal ischemia/reperfusion in rats. Shock 23 (2005) 330
15. Izumi Y., Gika M., Shinya N., et al. Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage. J Trauma 63 (2007) 783
16. Edwards G.A., Porter C.J., Caliph S.M., et al. Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev 50 (2001) 45
17. Kostopanagiotou G., Avgerinos E., Costopanagiotou C., et al. Acute lung injury in a rat model of intestinal ischemia-reperfusion: The potential time depended role of phospholipases A2. J Surg Res (2007) in press
18. Szalay L., Umar F., Khadem A., et al. Increased plasma D-lactate is associated with the severity of hemorrhagic/traumatic shock in rats. Shock 20 (2003) 245
19. Porras M., Martín M.T., Yang P.C., et al. Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis 12 (2006) 843
20. Chiu C.J., McArdle A.H., Brown R., et al. Intestinal mucosal lesion in low flow states: I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101 (1970) 478
21. Poeze M., Froon A.H., Greve J.W., et al. D-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair. Br J Surg 85 (1998) 1221
22. Mishima S., Xu D., Lu Q., et al. The relationship among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challenge in vivo. J Trauma 44 (1998) 175
23. Haddad J.J., and Land S.C. Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium. Am J Respir Cell Mol Biol 26 (2002) 114
24. Cavriani G., Domingos H.V., Oliveira-Filho R.M., et al. Lymphatic thoracic duct ligation modulates the serum levels of IL-1β and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor-α and nitric oxide. Shock 27 (2007) 209
25. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 34 Suppl (2001) 50
26. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res 9 (2003) 293
27. Ito K., Ozasa H., Kojima N., et al. Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat. Shock 19 (2003) 462
28. Yoshidome H., Lentsch A.B., Cheadle W.G., et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J Surg Res 81 (1999) 33